Loading clinical trials...
Loading clinical trials...
Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery - an International, Open-label, Non-controlled Study (NuDIMENSION)
Conditions
Interventions
Nuwiq
Locations
15
United States
UT Health San Antonio
San Antonio, Texas, United States
Helsinki University Hospital,Coagulation Disorder Unit
Helsinki, Finland
Avenue de la République
Chambray-lès-Tours, France
CHU de Nantes Hôtel-Dieu
Nantes, France
Universitätsklinikum Bonn,Institut für Experimentelle Haematologie und Transfusionsmedizin
Bonn, Germany
Gerinnungszentrum Rhein-Ruhr
Duisburg, Germany
Start Date
April 1, 2026
Primary Completion Date
February 1, 2027
Completion Date
February 1, 2027
Last Updated
January 13, 2026
NCT06820515
NCT07226206
NCT05987449
NCT04563520
NCT04645199
NCT06833983
Lead Sponsor
Octapharma
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions